Ph 1/2 Study Evaluating Safety and Tolerability of Inhaled AP-PA02 in Subjects With Chronic Pseudomonas Aeruginosa Lung Infections and Cystic Fibrosis

New York Medical College, Valhalla

The Hospital of the University of Pennsylvania, Philadelphia

Johns Hopkins University, Baltimore

Medical University of South Carolina, Charleston

University of South Florida, Tampa

Vanderbilt University Medical Center, Nashville

Nationwide Children's Hospital, Columbus

University Hospitals Cleveland Medical Center, Cleveland

Harper University Hospital, Detroit

University of Iowa, Iowa City

Northwestern University, Chicago

The University of Kansas Medical Center, Kansas City

University of Texas Southwestern, Dallas

St. Luke's Cystic Fibrosis Center of Idaho, Boise

Children's Hospital Los Angeles, Los Angeles

University of Washington, Seattle

Massachusetts General Hospital, Boston

Boston Children's Hospital, Boston

Rutgers Robert Wood Johnson Medical School, New Brunswick

University of Wisconsin, Madison